AGP Picks
View all

UK Healthcare Gazette
Provided by AGP

UK Healthcare Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on April 21, 2026

SkyBiometry Announces New Services to Design AI-Ready Infrastructure and Deliver Production-Ready AI Systems
Apr. 21, 2026

SkyBiometry Announces New Services to Design AI-Ready Infrastructure and Deliver Production-Ready AI Systems

Indeterminate EIN Presswire
Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026
Apr. 21, 2026

Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026

Indeterminate GlobeNewswire
These are the 10 AI trends to watch in 2026 that will drive business forward
Apr. 21, 2026

These are the 10 AI trends to watch in 2026 that will drive business forward

Indeterminate EIN Presswire
SOMAÍ to develop Bedrocan EU-GMP Cannabis Extracts for Global Medical Markets
Apr. 21, 2026

SOMAÍ to develop Bedrocan EU-GMP Cannabis Extracts for Global Medical Markets

Indeterminate EIN Presswire
Soft Skeletal Implants Market to Reach US$ 12.9 Billion by 2033, Growing at 6.3% CAGR | Persistence Market Research
Apr. 21, 2026

Soft Skeletal Implants Market to Reach US$ 12.9 Billion by 2033, Growing at 6.3% CAGR | Persistence Market Research

Indeterminate EIN Presswire
Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform
Apr. 21, 2026

Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform

Indeterminate GlobeNewswire
4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments
Apr. 21, 2026

4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments

Indeterminate GlobeNewswire
New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years
Apr. 21, 2026

New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years

Indeterminate GlobeNewswire
Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows
Apr. 21, 2026

Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows

Indeterminate GlobeNewswire
Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026
Apr. 21, 2026

Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026

Indeterminate GlobeNewswire
Rapid Nutrition Establishes Flagship Platform to Strengthen Multi-Channel Strategy in Australia
Apr. 21, 2026

Rapid Nutrition Establishes Flagship Platform to Strengthen Multi-Channel Strategy in Australia

Indeterminate GlobeNewswire
TRT UK - What Is TRT and Who Should Take a TRT Test? A Complete UK Guide
Apr. 21, 2026

TRT UK - What Is TRT and Who Should Take a TRT Test? A Complete UK Guide

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

UK Healthcare Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.